NPACT- Naturally occuring Plant based Anticancerous Compound-Activity-Target DataBase
NPACT
Naturally occuring Plant based Anticancerous Compound-Activity-Target DataBase
Home
Browse
Search
Advance Search
Data Submission
Compound:
Betulinic acid
Targets
Gene Name
Gene ID
Cancer
Cell Lines
IC
50
ED
50
EC
50
GI
50
Remark
References
CCND1
cyclin D1
595
Breast Carcinoma
T-47D
-
-
-
-
Betulinic acid induces dose-dependent changes in expression of cyclin D1 gene
16964520
CCND1
cyclin D1
595
Medulloblastoma
TE-671
-
-
-
-
Betulinic acid induces dose-dependent changes in expression of cyclin D1 gene
16964520
CCND1
cyclin D1
595
Multiple Myeloma
RPMI-8226
-
-
-
-
Betulinic acid induces dose-dependent changes in expression of cyclin D1 gene
16964520
CCND1
cyclin D1
595
Neuroblastoma
SK-N-AS
-
-
-
-
Betulinic acid induces dose-dependent changes in expression of cyclin D1 gene
16964520
CCND1
cyclin D1
595
T cell leukemia
Jurkat E6.1
-
-
-
-
Betulinic acid induces dose-dependent changes in expression of cyclin D1 gene
16964520
CCND1
cyclin D1
595
Thyroid carcinoma
FTC238
-
-
-
-
Betulinic acid induces dose-dependent changes in expression of cyclin D1 gene
16964520
CCND1
cyclin D1
595
Prostate Cancer
LNCaP
-
-
-
-
Relatively short-term exposure (24 h) to betulinic acid (>10 µmol/L) induced downregulation of cyclin D1, whereas the cyclin-dependent kinase inhibitors p21 and p27 were expressed at low levels in these cells and were not affected by the treatment.
17363604
Help
FAQs
Statistics
Tool
Contact
Copyright © 2012. Subhash M. Agagrwal. All Rights Reserved.